Description
An inhibitor of influenza virus PB2 (KD = ~1.6 µM) and inhibits the activity of Axl and CaMKIIβ by >50% in a panel of 65 human and rat kinases; decreases the replication of seven adamantine- and neuraminidase inhibitor-resistant strains of influenza virus A (EC50s = 50s = 0.58, 0.64, and 0.89, respectively, in a cell-based assay); increases survival in a mouse model of intranasal influenza A infection at 1, 3, and 10 mg/kg twice per day
Formal name: (2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-4-pyrimidinyl]amino]-bicyclo[2.2.2]octane-2-carboxylic acid
Synonyms: JNJ 63623872|JNJ 872|VX 787
Molecular weight: 399.4
CAS: 1629869-44-8
Purity: ≥98%
Formulation: A solid